Athira Pharma, Inc. announced Hans Moebius, MD, PhD, is retiring as Chief Medical Officer effective January 5, 2024, and will continue as Athira?s Senior Scientific Advisor. Dr. Moebius will serve as a full-time employee in the role of Senior Scientific Advisor reporting to the Company?s Chief Executive Officer. The Company has initiated a search to fill the Chief Medical Officer position.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | +4.90% | +0.78% | +5.76% |
May. 15 | Athira Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.76% | 98.5M | |
+55.70% | 59.34B | |
+42.72% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- ATHA Stock
- News Athira Pharma, Inc.
- Athira Pharma, Inc. Announces Hans Moebius Retires as Chief Medical Officer